Intestinal microbiome characterization of adult Brazilian men with psoriasis compared to omnivore and vegetarian controls by Tatiana Cristina Figueira Polo, Mariana Righetto de Ré Lai, Luciane Donida Bartoli Miot, Giovana Fernanda Cosi Bento, Márcia Guimarães da Silva, Silvio Alencar Marques, Hélio Amante Miot

Subjects: Get full text

The frequency of distribution of the genotypes of the IL4 polymorphism (rs 2243250) in psoriasis and psoriatic arthritis by A. A. Barilo, M. V. Smolnikova, S. V. Smirnova

Subjects: “…psoriasis…”
Get full text

SALBUTAMOL AMELIORATES THE PHENOTYPE OF THE SKIN INFLAMMATORY DISEASE PSORIASIS ACCORDING TO SKIN SPHEROID MODELS by Berke Demiriz, İrem Türkmen, Berna Aksoy, Özge Sezin Somuncu, Salih Somuncu

Subjects: “…psoriasis…”
Get full text

Serum Adenosine Deaminase Activity in Monitoring Disease Activity and Response to Therapy in Severe Psoriasis by Zülal Erbagci, A. Binnur Erbagci, Oya Köylüoglu, A. Almila Tuncel

Subjects: “…Psoriasis…”
Get full text

Risk of herpes zoster with IL-17 inhibitor therapy for psoriasis and other inflammatory conditions by Kevin K. Wu, Michael P. Lee, Erica B. Lee, Jashin J. Wu

Subjects: “…psoriasis…”
Get full text

Gene Ontology Analysis Highlights Biological Processes Influencing Responsiveness to Biological Therapy in Psoriasis by Martina Krušič, Gregor Jezernik, Uroš Potočnik

Subjects: “…psoriasis…”
Get full text

Treatment satisfaction among patients with psoriasis at a large academic center: an observational study by Toral S. Vaidya, Ali Alikhan

Get full text

Mannose-binding lectin gene polymorphism in psoriasis and vitiligo: an observational study and computational analysis by Mohammed Y. Behairy, Noha Z. Tawfik, Refaat A. Eid, Dalal Nasser Binjawhar, Dalal Sulaiman Alshaya, Eman Fayad, Walid F. Elkhatib, Walid F. Elkhatib, Hoda Y. Abdallah, Hoda Y. Abdallah

Subjects: “…psoriasis…”
Get full text

YouTube videos on oral systemic therapies for psoriasis: a cross-sectional analysis by Kelly A. Reynolds, Deeti J. Pithadia, Erica B. Lee, Jashin J. Wu

Get full text

Efects of metal oxide nanoparticles on healthy and psoriasis‑like human epidermal keratinocytes in vitro by Tan, Li Yi, Setyawati, Magdiel Inggrid, Ng, Kee Woei

“…Moreover, NP’s effect on common skin disorders like psoriasis, where barrier impairments and underlying inflammation could potentially increase NP penetration and worsen nanotoxicity is largely unstudied. …”
Get full text

PREVALENSI IgG ANTI HUMAN PAILLOMA VIRUS PADA PENDERITA PSORIASIS VULGARIS by , Maria, , dr. Fajar Waskito, Sp.KK(K)., M.Kes.

“…Psoriasis is a cell T mediated disease and activation of cell T (CD4) polyclonal lymphocyte T by superantigen, trauma, and another factor is the first step of psoriasis lesions. …”

A case of pustular psoriasis in a young boy / Meera Kuppusamy and Tarita Taib. by Kuppusamy, Meera, Taib, Tarita

“…Oral cyclosporine should be considered in patients with generalised pustular psoriasis complicated with transaminitis.…”
Get full text

2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis by Singh, J, Guyatt, G, Ogdie, A, Gladman, D, Deal, C, Deodhar, A, Dubreuil, M, Dunham, J, Husni, M, Kenny, S, Kwan-Morley, J, Lin, J, Marchetta, P, Mease, P, Merola, J, Miner, J, Ritchlin, C, Siaton, B, Smith, B, Van Voorhees, A, Jonsson, A, Shah, A, Sullivan, N, Turgunbaev, M, Coates, L, Gottlieb, A, Magrey, M, Nowell, W, Orbai, A, Reddy, S, Scher, J, Siegel, E, Siegel, M, Walsh, J, Turner, A, Reston, J

“…To develop an evidence- based guideline for the pharmacologic and nonpharmacologic treatment of psoriatic arthritis (PsA), as a collaboration between the American College of Rheumatology (ACR) and the National Psoriasis Foundation (NPF). <strong>Methods</strong>. …”

Targeted phototherapy of plaque-type psoriasis using ultraviolet B-light-emitting diodes. by Kemény, L, Csoma, Z, Bagdi, E, Banham, A, Krenács, L, Koreck, A

“…LEDs emitting in the ultraviolet (UV) B spectrum might serve as a more convenient alternative for targeted delivery of phototherapy in inflammatory skin diseases such as psoriasis. OBJECTIVES: We investigated the efficacy and safety of a new UVB-LED phototherapeutic device in chronic plaque-type psoriasis. …”

Acquired subepidermal bullous diseases associated with psoriasis: a clinical, immunopathological and immunogenetic study. by Kirtschig, G, Chow, E, Venning, V, Wojnarowska, F

“…Clinical, immunopathological and immunogenetic studies of four patients with a subepidermal bullous disease associated with psoriasis were carried out to determine the true nature of the blistering disease and to investigate further the relationship between psoriasis and acquired subepidermal bullous diseases. …”

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2023 - a pragmatic update. by Smith, CH, Yiu, ZZN, Bale, T, Burden, AD, Coates, LC, Eckert, E, Longley, N, Mahil, SK, McGuire, A, Murphy, R, Nelson-Piercy, C, Owen, CM, Parslew, R, Woolf, RT, Mansour Kiaee, Z, Constantin, AM, Ezejimofor, MC, Exton, LS, Mohd Mustapa, MF

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: A rapid update by Smith, CH, Yiu, ZZ, Bale, T, Burden, AD, Coates, LC, Edwards, W, MacMahon, E, Mahil, S, McGuire, A, Murphy, R, Nelson-Piercy, C, Owen, CM, Parslew, R, Uthman, OA, Woolf, RT, Manounah, L, Ezejimofor, M, Exton, LS, Mohd Mustapa, MF

“…The overall aim of the guideline is to provide up‐to‐date, evidence‐based recommendations on the use of biologic therapies targeting TNF (adalimumab, etanercept, certolizumab pegol, infliximab), IL12/23p40 (ustekinumab), IL17A (ixekizumab, secukinumab), IL17RA (brodalumab) and IL23p19 (guselkumab, risankizumab, tildrakizumab) in adults, children and young people for the treatment of psoriasis; consideration is given to the specific needs of people with psoriasis and psoriatic arthritis.…”

2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis by Singh, J, Guyatt, G, Ogdie, A, Gladman, D, Deal, C, Deodhar, A, Dubreuil, M, Dunham, J, Husni, M, Kenny, S, Kwan-Morley, J, Lin, J, Marchetta, P, Mease, P, Merola, J, Miner, J, Ritchlin, C, Siaton, B, Smith, B, Van Voorhees, A, Jonsson, A, Shah, A, Sullivan, N, Turgunbaev, M, Coates, L, Gottlieb, A, Magrey, M, Nowell, W, Orbai, A, Reddy, S, Scher, J, Siegel, E, Siegel, M, Walsh, J, Turner, A, Reston, J

“…<p><strong>Objective</strong></p> <p>To develop an evidence‐based guideline for the pharmacologic and nonpharmacologic treatment of psoriatic arthritis (PsA), as a collaboration between the American College of Rheumatology (ACR) and the National Psoriasis Foundation (NPF). <p><strong>Methods</strong></p> <p>We identified critical outcomes in PsA and clinically relevant PICO (population/intervention/comparator/outcomes) questions. …”

Patient perspectives on psoriatic disease burden: results from the global Psoriasis and Beyond survey by Armstrong, A, Bohannan, B, Mburu, S, Coates, LC, Ogdie, A, Alarcon, I, Kasparek, T, Frade, S, Fernandez Barrio, S, Augustin, M

“…Despite this, recognition of common manifestations and comorbidities associated with PsD was low. Among psoriasis-only patients (n=3490), 38% screened positive using the Psoriasis Epidemiology Screening Tool (PEST), indicative of potential PsA. …”

Variation at the IRF2 gene and susceptibility to psoriasis in chromosome 4q-linked families. by Parkinson, J, Charon, C, Baker, B, Powles, A, Rogers, S, Caird, A, Smedley, D, Halford, S, Fry, L, McCarthy, M

“…Evidence, largely from Irish pedigrees, indicates that a susceptibility locus for psoriasis maps to chromosome 4q. The gene encoding interferon regulatory factor-2 (IRF-2) maps to this region, and, as mice lacking IRF-2 exhibit a dermatologic phenotype resembling many aspects of human psoriasis, IRF-2 represents an attractive positional candidate. …”